SmallCaps
ASX:IIQHealth Care Equipment & ServicesHealth Care Services

Inoviq Ltd

INOVIQ Ltd is an Australia-based biotechnology company developing diagnostics and therapeutics for cancer.

$0.175▼ -$0.005 (-2.78%)AUD · Closed
-53.8%52-week return
Day Range
$0.170 – $0.180
52 Week Range
$0.165 – $0.565
Volume
404.53K
Avg Volume (10D)
124.29K
Market Cap
$24.64M
The company

The business

What Inoviq Ltd does

INOVIQ Ltd is an Australia-based biotechnology company developing diagnostics and therapeutics for cancer. The Company's commercialized products include EXO-NET exosome isolation technology for biomarker discovery and diagnostics development, and the hTERT test as an adjunct test for bladder cancer. The Company is also advancing clinical-stage diagnostics for the detection and monitoring of ovarian and breast cancers, and early-stage exosome therapeutics for solid tumors.

Incorporated
AUS
Public since
1991-04-18
Employees
85
Advertisement
Share price & key data

Share price

OHLC · volume · moving averages
$0.175-$0.150 (-46.15%)over 6M
Hi$0.565Lo$0.165
Price-sensitive newsVolumePrev close · 52W range

Market Statistics

Today
Open
$0.180
Prev Close
$0.180
Day High
$0.180
Day Low
$0.170
52wk High
$0.565
52wk Low
$0.165

Valuation

Multiples
Market Cap
$24.64M
Shares Out
140.78M
Price/Book
1.34

Trading Activity

Volume & book
Volume
404.53K
Value Traded
$69.77K
Bid
$0.170 × 201,866
Ask
$0.180 × 143,754
Avg Vol 10D
124.29K

Performance

Total return
1 Day
+2.86%
5 Day
+2.86%
13 Week
-46.27%
52 Week
-53.85%
YTD
-53.55%
Peers & news

Looking for charts & signals? See the tab.

◆ FREE MEMBER ACCESS

Unlock the full research library - free.

Create a free account to access every broker report, CEO interview, IPO alert, and daily market wrap. No credit card. No paywall.

✓Full broker research library
✓Complete CEO interview archive
✓IPO calendar and alerts
✓New research alerts
✓Mobile notifications
✓Members-only market wraps
◆ Free account
Start free
No credit card · Takes 30 seconds · 200,000+ members
Unlock free access →
Continue with Google or email through our secure Auth0 signup.